Posts tagged “liquidia”
Envisia Therapeutics, a spinout from Triangle-based nanotechology firm Liquidia, formally launched on Tuesday with investors committing $25 million to the new venture. The company will be run by Liquidia's current management team.
CEO Neal Fowler and the management team at Liquidia will be handling multiple roles as the nantotechnology firm formally spins out Envisia with $25 million in new funding. Fowler discusses the challenges and opportunities in an exclusive WRALTechWire Insider interview.
Joseph DeSimone, whose nanotechnology research in University of North Carolina at Chapel Hill labs formed the basis for spinout Liquidia Technologies, will step down as director of UNC's Kenan Institute of Private Enterprise 18 months after taking the top position.
This week Liquidia presented data from two preclinical studies at the annual meeting of the Association for Research in Vision and Ophtalmology, studies that offer a peek at ophtalmic applications Liquidia has been researching.
Nanotechnology company Liquidia plans to spin off a separate company. Read more about the therapeutic and financial opportunities Liquidia sees in eye drugs.
CED Life Science Conference 2013: Nanotechnology company Liquidia is considering spinning its research off into one, perhaps even two companies to pursue different targets utilizing its proprietary nanoparticle technology.
The Research Triangle Park-based firm is working with PATH to conduct preclinical studies on a "next generation" pneumococcal vaccine that could be more effective than existing vaccines and more efficient to produce.
- How student loan servicers affect tens of millions of people
- FACT CHECK: Trump starts on familiar note: with exaggeration
- Chinese express doubts about US relations under Trump
- Will Trump end globalization? The doubt haunts Davos' elite
- Matt Cohler helped build Facebook, Snapchat, LinkedIn and Uber. Here's his advice for startups